Efficacy of PENG and anterior quadratus lumborum nerve block in hip fracture surgery .
Comparison of the postoperative analgesic efficacy of pericapsular nerve group block (PENG) and anterior quadratus lumborum block in hip fracture surgery: A prospective randomized study.
Sci Prog. 2025 01-Oct:. 10.1177/00368504251382032Study Summary
90 patients undergoing hip fracture surgery were randomized to receive either a pericapsular nerve group block (PENG) or an anterior quadratus lumborum block (QLB) following surgery. After exclusions related to postoperative complications, prolonged ICU stay, protocol deviations, and inability to perform the block, 73 patients were included in the final analysis, with 43 patients in the PENG group and 30 patients in the anterior QLB group. The primary outcome of interest was total tramadol consumption within the first 48 postoperative hours. Secondary outcomes included time to first rescue analgesia, resting and dynamic Numeric Rating Scale pain scores at 2, 12, 24, and 48 hours, and block-related adverse effects, including quadriceps weakness and nausea. Outcomes were assessed during the first 48 hours postoperatively. Overall, the results of the study revealed that patients receiving the PENG block required significantly less opioid analgesia and experienced a longer duration before first rescue analgesia compared with those receiving the anterior QLB, while pain scores were comparable between groups.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics